Navigation Links
Common Heart Drug Linked to Cancer Risk in Study
Date:4/8/2013

By Steven Reinberg
HealthDay Reporter

MONDAY, April 8 (HealthDay News) -- A drug called amiodarone that's widely used to treat heartbeat irregularities might raise a patient's risk of cancer, Taiwanese researchers report.

The risk, which the researchers termed "borderline significantly increased," is more pronounced in men and patients who take high doses of the drug, according to the study, which was published online April 8 in the journal Cancer.

"When prescribing amiodarone, doctors need to keep in mind that this medication may increase cancer risk," said lead author Dr. Vincent Yi-Fong Su, from the Taipei Veterans General Hospital. "We suggest that cancer events should be routinely reported in future amiodarone trials, and further observational research is necessary."

Patients taking the drug, however, shouldn't fear they'll get cancer, one expert said.

"Amiodarone is among the most effective antiarrhythmic medications available," said Dr. Gregg Fonarow, a spokesman for the American Heart Association and professor of cardiology at the University of California, Los Angeles. "Well-controlled clinical trials have not demonstrated a significant increase in cancer with use of this medication."

The current study, called an observational study, doesn't prove that amiodarone causes cancer, only that an association was found between people taking the drug and cancer.

Many risk factors for heart disease and arrhythmia are also risk factors for cancer, Fonarow said. The findings of this study comparing those treated with amiodarone to the general population are most likely explained by selection of patients and other factors that weren't taken into account, he said.

"These findings should not be a concern to patients taking amiodarone," Fonarow said.

Amiodarone (sold as Cordarone and Pacerone) is commonly prescribed to prevent life-threatening arrhythmias, such as ventricular tac
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Common Asphalt Sealant May Raise Cancer Risks
2. Life Extension Foundation Seeks Volunteers with Alzheimer's to Participate in a Clinical Trial Utilizing a Common Arthritis Drug
3. LSUHSC research discoveries shed light on common STI
4. Researchers are first to use common virus to fortify adult stem cells
5. Common gene variants explain 42 percent of antidepressant response
6. Paranoia Common After Mugging, Study Says
7. Hospital remains most common place of death for cancer patients in England
8. Commonly used cholesterol calculation underestimates heart disease danger for many
9. Michigan hospitals national leaders in preventing common and costly urinary tract infections
10. How common is The John Next Door?
11. Complications More Common Than Thought for Type of Hip Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Common Heart Drug Linked to Cancer Risk in Study
(Date:7/6/2015)... ... July 06, 2015 , ... For over twenty years, ... personal injury victims. Throughout the company’s history the goal has been to be ... need in their recovery. And while Doctors on Liens has certainly achieved that ...
(Date:7/6/2015)... ... July 06, 2015 , ... PristineHydro ( http://www.pristinewaterfilters.com ) has ... and impurities; it also properly mineralizes the water with electrolyte salts.  Common tap ... harmful contaminants are a byproduct of how the water is treated chemically.  In ...
(Date:7/6/2015)... ... ... in a report titled “ Female Hair Loss Needs to be Talked About, Shed Stigma, ... in the U.S. will suffer from thinning hair or hair loss . For these 30 ... former beauty queen, who was interviewed for the report began losing her hair at age 11 ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... year for aesthetic reasons, which is why liposuction regularly ranks among the top ... however, fat reduction has become more than a way to slim down a ...
(Date:7/6/2015)... ... July 06, 2015 , ... doTERRA, the leading global essential oils ... team. Most recently, Jowers held the position as Director of the Hinckley Institute at ... a decade building the institute, Jowers states that he was ready for a new ...
Breaking Medicine News(10 mins):Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:Pristine Water Filters.com Offers The 1st Water Revival System That Re-Mineralizes Drinking Water and Eliminates All Impurities and Chemicals 2Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4
... partners and installations drive adoption of PLUS in Real-Time Location ... ... Ala., Jan. 28 Time Domain Corporation, (http://www.timedomain.com ), a ... announced the first eleven partners to its,global channel reseller network ...
... equivalent of 4 cups a day led to spikes in ... New research suggests the caffeine in those daily cups of ... a small group of 10 diabetics, glucose levels rose by ... of caffeine found in four cups of coffee. , "There,s ...
... articles abound in the,news, with many of them focused on ... people being under-treated, or those that suffer,from conditions like back ... to the Centers for Disease Control and Prevention (CDC),roughly 25 ... Estimates,put the number of people hurting at around 50 million. ...
... Bulletin,Board: NTRZ), a world leader in stabilized rice bran ... its domestic,operations., The Company stated that its Stage ... full capacity since the middle of the fourth,quarter and ... disassembled for,cleaning. Further, the facility is fully committed to ...
... Time -, SAN FRANCISCO, Jan. 28 Medivation, ... its end-of-Phase 2 meeting,with the U.S. Food and Drug ... Phase 3 trial of Dimebon(TM) for,mild-to-moderate Alzheimer,s Disease in ... Medivation that the company,s previously completed,trial conducted in Russia ...
... Insight into Pharmaceutical Information Use and ... Online Media ... in,syndicated research and marketing services for the health and,pharmaceutical industry, announced ... for subscribing clients.,This online study of U.S. consumers includes trended data ...
Cached Medicine News:Health News:Time Domain Adds Eleven Partners to its Channel Reseller Network of PLUS(TM) Ultra Wideband Solutions Providers 2Health News:Time Domain Adds Eleven Partners to its Channel Reseller Network of PLUS(TM) Ultra Wideband Solutions Providers 3Health News:Caffeine Could Spell Trouble for Diabetics 2Health News:What You Don't Know About Pain Management Could Hurt You 2Health News:NutraCea Provides Update on Domestic Operations 2Health News:NutraCea Provides Update on Domestic Operations 3Health News:Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimer's Disease in Second Quarter of 2008 2Health News:Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimer's Disease in Second Quarter of 2008 3Health News:Manhattan Research: ePharma Consumer(R) Research and Advisory Service Now Available 2
(Date:7/6/2015)... July 6, 2015 Cardinal Health today announced ... Group (THDG). A distributor of generic pharmaceuticals, over-the-counter medications and ... THDG was owned by Court Square Capital Partners. The ... cash and new debt.  Headquartered in ... Group had revenues of approximately $450 million in 2014. ...
(Date:7/6/2015)... 29, 2015 Research and ... "Urinary Slings Market in the US 2015-2019" ... the Urinary Slings market in the US to grow ... 2014-2019. This report covers the present scenario and ... the US for the period 2015-2019. To calculate the ...
(Date:7/6/2015)... , June 29, 2015 ... addition of the "Pharmaceutical Grade Sodium Chloride Market ... to 2019" report to their offering. ... witness a CAGR of 6.9% between 2014 and 2019 ... to reach 690 KT by 2019. The ...
Breaking Medicine Technology:Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3
... NASHVILLE, Tenn. , April 26 Cumberland Pharmaceuticals Inc. ... preference study evaluating Kristalose® ( lactulose ) for Oral Solution, a prescription ... Digestive Disease Week® meeting in New Orleans .   , ... A poster presentation of the study, ...
... DIEGO , April 26 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... of Neurocrine Biosciences, will be presenting at the Deutsche Bank 35th Annual Health ... , , ... 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time . ...
Cached Medicine Technology:Kristalose(R) Clinical Data to Be Presented at Digestive Disease Week(R) Meeting 2Kristalose(R) Clinical Data to Be Presented at Digestive Disease Week(R) Meeting 3Neurocrine Biosciences to Present at the Deutsche Bank 35th Annual Health Care Conference 2
... Medical is the world leader in ... used worldwide for permanent pacemaker and ... and port implantation, and for temporary ... St. Jude Medical Peel-Away introducers includes ...
... Self-Expanding Stent System combines low-profile, high radial force, ... guide wire compatible stent system provides 6F sheath ... (5.0 - 10.0 mm). Now, with longer stents ... five stent lengths (28, 38, 56, 80 and ...
... left heart catheterization occurs when the initial ... sheath with an alternate curve while maintaining ... exchange has required a repeat septal puncture--complex ... overcome this problem with the unique PERRY ...
Coaxial Multicolor LIO Worlds first coaxial multicolor LIO provides precise laser delivery with repeatable outcomes, as well as maximum treatment options and physician safety....
Medicine Products: